{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T11:57:25Z","timestamp":1780055845617,"version":"3.54.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,2,24]],"date-time":"2016-02-24T00:00:00Z","timestamp":1456272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2016,2,24]],"date-time":"2016-02-24T00:00:00Z","timestamp":1456272000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Safflower has long been used to treat cerebrovascular diseases in China. We previously reported that kaempferol derivatives of safflower can bind DJ-1, a protein associated with Parkinson\u2019s disease (PD) and flavonoid extract of safflower exhibited neuroprotective effects in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced mouse model of PD. In this study, a standardized safflower flavonoid extract (SAFE) was isolated from safflower and mainly contained flavonoids. Two marker compounds of SAFE, kaempferol 3-O-rutinoside and anhydrosafflor yellow B, were proven to suppress microtubule destabilization and decreased cell area, respectively. We confirmed that SAFE in dripping pill form could improve behavioural performances in a 6-hydroxydopamine (6-OHDA)-induced rat model of PD, partially via the suppression of \u03b1-synuclein overexpression or aggregation, as well as the suppression of reactive astrogliosis. Using an MRI tracer-based method, we found that 6-OHDA could change extracellular space (ECS) diffusion parameters, including a decrease in tortuosity and the rate constant of clearance and an increase in the elimination half-life of the tracer in the 6-OHDA-lesioned substantia nigra. SAFE treatment could partially inhibit the changes in ECS diffusion parameters, which might provide some information about neuronal loss and astrocyte activation. Consequently, our results indicate that SAFE is a potential therapeutic herbal product for treatment of PD.<\/jats:p>","DOI":"10.1038\/srep22135","type":"journal-article","created":{"date-parts":[[2016,2,24]],"date-time":"2016-02-24T11:00:02Z","timestamp":1456311602000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":68,"title":["Neuroprotective Effects of A Standardized Flavonoid Extract of Safflower Against Neurotoxin-Induced Cellular and Animal Models of Parkinson\u2019s Disease"],"prefix":"10.1038","volume":"6","author":[{"given":"Rutong","family":"Ren","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunyan","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongfei","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanjie","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuramatjan","family":"Ablat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiamin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingcong","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianrong","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoping","family":"Pu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongbin","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,2,24]]},"reference":[{"key":"BFsrep22135_CR1","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.arr.2014.01.004","volume":"14","author":"A Reeve","year":"2014","unstructured":"Reeve, A., Simcox, E. & Turnbull, D. Ageing and Parkinson\u2019s disease: why is advancing age the biggest risk factor? Ageing Res. Rev. 14, 19\u201330 (2014).","journal-title":"Ageing Res. Rev."},{"key":"BFsrep22135_CR2","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S0896-6273(03)00568-3","volume":"39","author":"W Dauer","year":"2003","unstructured":"Dauer, W. & Przedborski, S. Parkinson\u2019s disease: mechanisms and models. Neuron 39, 889\u2013909 (2003).","journal-title":"Neuron"},{"key":"BFsrep22135_CR3","doi-asserted-by":"crossref","first-page":"e31439","DOI":"10.1371\/journal.pone.0031439","volume":"7","author":"L Tian","year":"2012","unstructured":"Tian, L. et al. No differential regulation of dopamine transporter (DAT) and vesicular monoamine transporter 2 (VMAT2) binding in a primate model of Parkinson disease. PLoS One 7, e31439 (2012).","journal-title":"PLoS One"},{"key":"BFsrep22135_CR4","doi-asserted-by":"crossref","first-page":"4465","DOI":"10.3390\/ijms11114465","volume":"11","author":"VZ Klusa","year":"2010","unstructured":"Klusa, V. Z. et al. Neuroprotective properties of mildronate, a small molecule, in a rat model of Parkinson\u2019s disease. Int. J. Mol. Sci. 11, 4465\u20134487 (2010).","journal-title":"Int. J. Mol. Sci."},{"key":"BFsrep22135_CR5","first-page":"519615","volume":"2014","author":"I Calou","year":"2014","unstructured":"Calou, I. et al. Neuroprotective Properties of a Standardized Extract from Myracrodruon urundeuva Fr. All. (Aroeira-Do-Sertao), as Evaluated by a Parkinson\u2019s Disease Model in Rats. Parkinsons Dis. 2014, 519615 (2014).","journal-title":"Parkinsons Dis"},{"key":"BFsrep22135_CR6","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1111\/nan.12077","volume":"40","author":"YY Sun","year":"2014","unstructured":"Sun, Y. Y. et al. Fasciculation and elongation protein zeta-1 (FEZ1) expression in reactive astrocytes in a rat model of Parkinson\u2019s disease. Neuropathol. Appl. Neurobiol. 40, 164\u2013176 (2014).","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"BFsrep22135_CR7","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.brainresbull.2012.05.013","volume":"88","author":"SY Sun","year":"2012","unstructured":"Sun, S. Y., An, C. N. & Pu, X. P. DJ-1 protein protects dopaminergic neurons against 6-OHDA\/MG-132-induced neurotoxicity in rats. Brain Res. Bull. 88, 609\u2013616 (2012).","journal-title":"Brain Res. Bull."},{"key":"BFsrep22135_CR8","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1002\/jnr.23318","volume":"92","author":"C Aureli","year":"2014","unstructured":"Aureli, C. et al. 5-S-cysteinyldopamine neurotoxicity: Influence on the expression of alpha-synuclein and ERp57 in cellular and animal models of Parkinson\u2019s disease. J. Neurosci. Res. 92, 347\u2013358 (2014).","journal-title":"J. Neurosci. Res."},{"key":"BFsrep22135_CR9","doi-asserted-by":"crossref","first-page":"25","DOI":"10.2131\/jts.38.25","volume":"38","author":"N Haleagrahara","year":"2013","unstructured":"Haleagrahara, N., Siew, C. J. & Ponnusamy, K. Effect of quercetin and desferrioxamine on 6-hydroxydopamine (6-OHDA) induced neurotoxicity in striatum of rats. J. Toxicol. Sci. 38, 25\u201333 (2013).","journal-title":"J. Toxicol. Sci."},{"key":"BFsrep22135_CR10","first-page":"1605","volume":"9","author":"P Bargiotas","year":"2013","unstructured":"Bargiotas, P. & Konitsiotis, S. Levodopa-induced dyskinesias in Parkinson\u2019s disease: emerging treatments. Neuropsychiatr. Dis. Treat. 9, 1605\u20131617 (2013).","journal-title":"Neuropsychiatr. Dis. Treat"},{"key":"BFsrep22135_CR11","doi-asserted-by":"crossref","first-page":"273","DOI":"10.2174\/187152707781387288","volume":"6","author":"LW Chen","year":"2007","unstructured":"Chen, L. W., Wang, Y. Q., Wei, L. C., Shi, M. & Chan, Y. S. Chinese herbs and herbal extracts for neuroprotection of dopaminergic neurons and potential therapeutic treatment of Parkinson\u2019s disease. CNS. Neurol. Disord. Drug Targets. 6, 273\u2013281 (2007).","journal-title":"CNS. Neurol. Disord. Drug Targets"},{"key":"BFsrep22135_CR12","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.neuroscience.2015.02.048","volume":"293","author":"SR Jahromi","year":"2015","unstructured":"Jahromi, S. R., Haddadi, M., Shivanandappa, T. & Ramesh, S. R. Attenuation of neuromotor deficits by natural antioxidants of Decalepis hamiltonii in transgenic Drosophila model of Parkinson\u2019s disease. Neuroscience 293, 136\u2013150 (2015).","journal-title":"Neuroscience"},{"key":"BFsrep22135_CR13","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1016\/j.chroma.2008.03.046","volume":"1216","author":"L Fan","year":"2009","unstructured":"Fan, L. et al. Qualitative evaluation and quantitative determination of 10 major active components in Carthamus tinctorius L. by high-performance liquid chromatography coupled with diode array detector. J. Chromatogr A. 1216, 2063\u20132070 (2009).","journal-title":"J. Chromatogr A."},{"key":"BFsrep22135_CR14","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1254\/jphs.09045FP","volume":"110","author":"W Qu","year":"2009","unstructured":"Qu, W. et al. Kaempferol derivatives prevent oxidative stress-induced cell death in a DJ-1-dependent manner. J. Pharmacol. Sci. 110, 191\u2013200 (2009).","journal-title":"J. Pharmacol. Sci."},{"key":"BFsrep22135_CR15","doi-asserted-by":"crossref","first-page":"e55839","DOI":"10.1371\/journal.pone.0055839","volume":"8","author":"L Yu","year":"2013","unstructured":"Yu, L. et al. Neuroprotective effect of kaempferol glycosides against brain injury and neuroinflammation by inhibiting the activation of NF-kappaB and STAT3 in transient focal stroke. PLoS One 8, e55839 (2013).","journal-title":"PLoS One"},{"key":"BFsrep22135_CR16","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1016\/j.jep.2013.12.003","volume":"151","author":"Y Wang","year":"2014","unstructured":"Wang, Y. et al. Antinociceptive and anti-inflammatory activities of extract and two isolated flavonoids of Carthamus tinctorius L. J. Ethnopharmacol. 151, 944\u2013950 (2014).","journal-title":"J. Ethnopharmacol."},{"key":"BFsrep22135_CR17","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ejphar.2013.06.011","volume":"714","author":"B Han","year":"2013","unstructured":"Han, B. et al. Neuroprotective effect of hydroxysafflor yellow A on 6-hydroxydopamine-induced Parkinson\u2019s disease in rats. Eur. J. Pharmacol. 714, 83\u201388 (2013).","journal-title":"Eur. J. Pharmacol."},{"key":"BFsrep22135_CR18","first-page":"355","volume":"20","author":"Q Wu","year":"2011","unstructured":"Wu, Q., Ye, M. & Pu, X. Neuroprotective effect of CTE, an extract from traditional Chinese medicine, in a mouse model of MPTP-induced Parkinson\u2019s disease. Chinese Journal of New Drugs 20, 355\u2013358 (2011).","journal-title":"Chinese Journal of New Drugs"},{"key":"BFsrep22135_CR19","unstructured":"Pu, X., Qu, W., Wu, Q. & Ye, M. The applications for safflower extract in the prevention and treatment of Neurodegenerative diseases. Vol. CN102526157A (Patent, China, 2012)."},{"key":"BFsrep22135_CR20","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1152\/physrev.00027.2007","volume":"88","author":"E Sykova","year":"2008","unstructured":"Sykova, E. & Nicholson, C. Diffusion in brain extracellular space. Physiol. Rev. 88, 1277\u20131340 (2008).","journal-title":"Physiol. Rev."},{"key":"BFsrep22135_CR21","doi-asserted-by":"crossref","first-page":"5567","DOI":"10.1073\/pnas.0509425103","volume":"103","author":"RG Thorne","year":"2006","unstructured":"Thorne, R. G. & Nicholson, C. In vivo diffusion analysis with quantum dots and dextrans predicts the width of brain extracellular space. Proc. Natl. Acad. Sci. USA. 103, 5567\u20135572 (2006).","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"BFsrep22135_CR22","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S0531-5565(98)00038-2","volume":"33","author":"E Sykova","year":"1998","unstructured":"Sykova, E., Mazel, T. & Simonova, Z. Diffusion constraints and neuron-glia interaction during aging. Exp. Gerontol. 33, 837\u2013851 (1998).","journal-title":"Exp. Gerontol."},{"key":"BFsrep22135_CR23","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/S0165-6147(99)01343-7","volume":"20","author":"M Zoli","year":"1999","unstructured":"Zoli, M., Jansson, A., Sykova, E., Agnati, L. F. & Fuxe, K. Volume transmission in the CNS and its relevance for neuropsychopharmacology. Trends Pharmacol. Sci. 20, 142\u2013150 (1999).","journal-title":"Trends Pharmacol. Sci."},{"key":"BFsrep22135_CR24","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0079-6123(00)25008-5","volume":"125","author":"E Sykova","year":"2000","unstructured":"Sykova, E., Mazel, T., Vargova, L., Vorisek, I. & Prokopova-Kubinova, S. Extracellular space diffusion and pathological states. Prog. Brain Res. 125, 155\u2013178 (2000).","journal-title":"Prog. Brain Res."},{"key":"BFsrep22135_CR25","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1080\/10286020801948540","volume":"10","author":"JS Jiang","year":"2008","unstructured":"Jiang, J. S., Lu, L., Yang, Y. J., Zhang, J. L. & Zhang, P. C. New spermidines from the florets of Carthamus tinctorius. J. Asian Nat. Prod. Res. 10, 447\u2013451 (2008).","journal-title":"J. Asian Nat. Prod. Res."},{"key":"BFsrep22135_CR26","unstructured":"Chinese Pharmacopoeia Commission. Part one of Chinese Pharmacopoeia. (ed. Chinese Pharmacopoeia Commission) 372\u2013373; The Appendix of Part one of Chinese Pharmacopoeia. (ed. Chinese Pharmacopoeia Commission) IK and XII A. (China medical science press, Beijing, 2010)."},{"key":"BFsrep22135_CR27","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1109\/JBHI.2014.2308279","volume":"18","author":"H Han","year":"2014","unstructured":"Han, H. et al. A novel MRI tracer-based method for measuring water diffusion in the extracellular space of the rat brain. IEEE J. Biomed. Health Inform. 18, 978\u2013983 (2014).","journal-title":"IEEE J. Biomed. Health Inform."},{"key":"BFsrep22135_CR28","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1177\/1087057110369703","volume":"15","author":"M Freeley","year":"2010","unstructured":"Freeley, M. et al. A high-content analysis toolbox permits dissection of diverse signaling pathways for T lymphocyte polarization. J. Biomol. Screen. 15, 541\u2013555 (2010).","journal-title":"J. Biomol. Screen."},{"key":"BFsrep22135_CR29","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.neuro.2014.03.013","volume":"42","author":"MS Wilson","year":"2014","unstructured":"Wilson, M. S., Graham, J. R. & Ball, A. J. Multiparametric High Content Analysis for assessment of neurotoxicity in differentiated neuronal cell lines and human embryonic stem cell-derived neurons. Neurotoxicology 42, 33\u201348 (2014).","journal-title":"Neurotoxicology"},{"key":"BFsrep22135_CR30","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.bbrc.2012.08.042","volume":"426","author":"H Hongo","year":"2012","unstructured":"Hongo, H. et al. Glycogen synthase kinase-3beta activation mediates rotenone-induced cytotoxicity with the involvement of microtubule destabilization. Biochem. Biophys. Res. Commun. 426, 94\u201399 (2012).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"BFsrep22135_CR31","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.neurobiolaging.2012.04.008","volume":"34","author":"C Sheng","year":"2013","unstructured":"Sheng, C. et al. DJ-1 deficiency perturbs microtubule dynamics and impairs striatal neurite outgrowth. Neurobiol. Aging. 34, 489\u2013498 (2013).","journal-title":"Neurobiol. Aging."},{"key":"BFsrep22135_CR32","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1021\/np9904049","volume":"62","author":"VE Tyler","year":"1999","unstructured":"Tyler, V. E. Phytomedicines: back to the future. J. Nat. Prod. 62, 1589\u20131592 (1999).","journal-title":"J. Nat. Prod."},{"key":"BFsrep22135_CR33","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1016\/j.fct.2011.12.004","volume":"50","author":"TH Kim","year":"2012","unstructured":"Kim, T. H., Ku, S. K. & Bae, J. S. Inhibitory effects of kaempferol-3-O-sophoroside on HMGB1-mediated proinflammatory responses. Food Chem. Toxicol. 50, 1118\u20131123 (2012).","journal-title":"Food Chem. Toxicol."},{"key":"BFsrep22135_CR34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12640-011-9295-2","volume":"22","author":"MM Khan","year":"2012","unstructured":"Khan, M. M. et al. Rutin protects dopaminergic neurons from oxidative stress in an animal model of Parkinson\u2019s disease. Neurotox. Res. 22, 1\u201315 (2012).","journal-title":"Neurotox. Res."},{"key":"BFsrep22135_CR35","doi-asserted-by":"crossref","unstructured":"Magalingam, K. B., Radhakrishnan, A., Ramdas, P. & Haleagrahara, N. Quercetin Glycosides Induced Neuroprotection by Changes in the Gene Expression in a Cellular Model of Parkinson\u2019s Disease. J. Mol. Neurosci. (2014).","DOI":"10.1007\/s12031-014-0400-x"},{"key":"BFsrep22135_CR36","first-page":"278273","volume":"2012","author":"SL Xu","year":"2012","unstructured":"Xu, S. L. et al. Isorhamnetin, A Flavonol Aglycone from Ginkgo biloba L., Induces Neuronal Differentiation of Cultured PC12 Cells: Potentiating the Effect of Nerve Growth Factor. Evid. Based Complement. Alternat. Med. 2012, 278273 (2012).","journal-title":"Evid. Based Complement. Alternat. Med."},{"key":"BFsrep22135_CR37","doi-asserted-by":"crossref","first-page":"3903","DOI":"10.4161\/15384101.2014.973309","volume":"13","author":"S Buttner","year":"2014","unstructured":"Buttner, S. et al. Spermidine protects against alpha-synuclein neurotoxicity. Cell Cycle 13, 3903\u20133908 (2014).","journal-title":"Cell Cycle"},{"key":"BFsrep22135_CR38","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.fct.2014.03.018","volume":"68","author":"K Valentova","year":"2014","unstructured":"Valentova, K., Vrba, J., Bancirova, M., Ulrichova, J. & Kren, V. Isoquercitrin: pharmacology, toxicology and metabolism. Food Chem. Toxicol. 68, 267\u2013282 (2014).","journal-title":"Food Chem. Toxicol."},{"key":"BFsrep22135_CR39","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.3390\/molecules16021471","volume":"16","author":"AK Jager","year":"2011","unstructured":"Jager, A. K. & Saaby, L. Flavonoids and the CNS. Molecules 16, 1471\u20131485 (2011).","journal-title":"Molecules"},{"key":"BFsrep22135_CR40","first-page":"101","volume":"31","author":"YQ Zhou","year":"2006","unstructured":"Zhou, Y. Q., Chen, Y. J. & Feng, Q. R. Advances of studies on dropping pills. Zhongguo Zhong Yao Za Zhi 31, 101\u2013105 (2006).","journal-title":"Zhongguo Zhong Yao Za Zhi"},{"key":"BFsrep22135_CR41","doi-asserted-by":"crossref","first-page":"e78220","DOI":"10.1371\/journal.pone.0078220","volume":"8","author":"X Zhao","year":"2013","unstructured":"Zhao, X. et al. Neuroprotective effects of protocatechuic aldehyde against neurotoxin-induced cellular and animal models of Parkinson\u2019s disease. PLoS One 8, e78220 (2013).","journal-title":"PLoS One"},{"key":"BFsrep22135_CR42","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/S1474-4422(11)70213-7","volume":"10","author":"K Vekrellis","year":"2011","unstructured":"Vekrellis, K., Xilouri, M., Emmanouilidou, E., Rideout, H. J. & Stefanis, L. Pathological roles of alpha-synuclein in neurological disorders. Lancet Neurol. 10, 1015\u20131025 (2011).","journal-title":"Lancet Neurol."},{"key":"BFsrep22135_CR43","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1177\/0960327112468172","volume":"32","author":"R Satpute","year":"2013","unstructured":"Satpute, R., Lomash, V., Kaushal, M. & Bhattacharya, R. Neuroprotective effects of alpha-ketoglutarate and ethyl pyruvate against motor dysfunction and oxidative changes caused by repeated 1-methyl-4-phenyl-1,2,3,6 tetrahydropyridine exposure in mice. Hum. Exp. Toxicol. 32, 747\u2013758 (2013).","journal-title":"Hum. Exp. Toxicol."},{"key":"BFsrep22135_CR44","first-page":"139","volume":"7","author":"V Joers","year":"2014","unstructured":"Joers, V., Vermilyea, S., Dilley, K. & Emborg, M. E. Systemic administration of 6-OHDA to rhesus monkeys upregulates HLA-DR expression in brain microvasculature. J. Inflamm. Res. 7, 139\u2013149 (2014).","journal-title":"J. Inflamm. Res."},{"key":"BFsrep22135_CR45","first-page":"869","volume":"53","author":"M Catala","year":"2012","unstructured":"Catala, M. & Poirier, J. Georges Marinesco (1863\u20131938): neurologist, neurohistologist and neuropathologist. J. Morphol. Embryol. 53, 869\u2013877 (2012).","journal-title":"J. Morphol. Embryol."},{"key":"BFsrep22135_CR46","doi-asserted-by":"crossref","first-page":"e51996","DOI":"10.1371\/journal.pone.0051996","volume":"7","author":"PP Yao","year":"2012","unstructured":"Yao, P. P. et al. Enterovirus 71-induced neurological disorders in young gerbils, Meriones unguiculatus: development and application of a neurological disease model. PLoS One 7, e51996 (2012).","journal-title":"PLoS One"},{"key":"BFsrep22135_CR47","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1002\/jnr.10332","volume":"70","author":"T Reum","year":"2002","unstructured":"Reum, T. et al. Diffusion parameters in the striatum of rats with 6-hydroxydopamine-induced lesions and with fetal mesencephalic grafts. J. Neurosci. Res. 70, 680\u2013693 (2002).","journal-title":"J. Neurosci. Res."},{"key":"BFsrep22135_CR48","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/j.mri.2011.02.019","volume":"29","author":"F Xu","year":"2011","unstructured":"Xu, F., Han, H., Zhang, H., Pi, J. & Fu, Y. Quantification of Gd-DTPA concentration in neuroimaging using T(1)3D MP-RAGE sequence at 3.0 T. Magn. Reson. Imaging. 29, 827\u2013834 (2011).","journal-title":"Magn. Reson. Imaging."},{"key":"BFsrep22135_CR49","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.neulet.2013.02.071","volume":"543","author":"K Li","year":"2013","unstructured":"Li, K. et al. Real-time magnetic resonance imaging visualization and quantitative assessment of diffusion in the cerebral extracellular space of C6 glioma-bearing rats. Neurosci. Lett. 543, 84\u201389 (2013).","journal-title":"Neurosci. Lett."},{"key":"BFsrep22135_CR50","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1002\/(SICI)1098-1136(199910)28:1<40::AID-GLIA5>3.0.CO;2-6","volume":"28","author":"T Roitbak","year":"1999","unstructured":"Roitbak, T. & Sykova, E. Diffusion barriers evoked in the rat cortex by reactive astrogliosis. Glia 28, 40\u201348 (1999).","journal-title":"Glia"},{"key":"BFsrep22135_CR51","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s00702-004-0204-1","volume":"112","author":"C Nicholson","year":"2005","unstructured":"Nicholson, C. Factors governing diffusing molecular signals in brain extracellular space. J. Neural Transm. 112, 29\u201344 (2005).","journal-title":"J. Neural Transm."},{"key":"BFsrep22135_CR52","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1097\/00004647-200109000-00005","volume":"21","author":"L Vargova","year":"2001","unstructured":"Vargova, L., Jendelova, P., Chvatal, A. & Sykova, E. Glutamate, NMDA and AMPA induced changes in extracellular space volume and tortuosity in the rat spinal cord. J. Cereb. Blood Flow. Metab. 21, 1077\u20131089 (2001).","journal-title":"J. Cereb. Blood Flow. Metab."},{"key":"BFsrep22135_CR53","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.neuropharm.2014.05.024","volume":"85","author":"A El Arfani","year":"2014","unstructured":"El Arfani, A. et al. NMDA receptor antagonism potentiates the L-DOPA-induced extracellular dopamine release in the subthalamic nucleus of hemi-parkinson rats. Neuropharmacology 85, 198\u2013205 (2014).","journal-title":"Neuropharmacology"},{"key":"BFsrep22135_CR54","doi-asserted-by":"crossref","first-page":"147ra111","DOI":"10.1126\/scitranslmed.3003748","volume":"4","author":"JJ Iliff","year":"2012","unstructured":"Iliff, J. J. et al. A paravascular pathway facilitates CSF flow through the brain parenchyma and the clearance of interstitial solutes, including amyloid beta. Sci. Transl. Med. 4, 147ra111 (2012).","journal-title":"Sci. Transl. Med."},{"key":"BFsrep22135_CR55","doi-asserted-by":"crossref","first-page":"e0116841","DOI":"10.1371\/journal.pone.0116841","volume":"10","author":"M Shahaduzzaman","year":"2015","unstructured":"Shahaduzzaman, M. et al. Anti-human alpha-synuclein N-terminal peptide antibody protects against dopaminergic cell death and ameliorates behavioral deficits in an AAV-alpha-synuclein rat model of Parkinson\u2019s disease. PLoS One 10, e0116841 (2015).","journal-title":"PLoS One"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/srep22135","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep22135.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep22135.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,4]],"date-time":"2023-01-04T14:11:09Z","timestamp":1672841469000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/srep22135"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2,24]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2016,4,20]]}},"alternative-id":["BFsrep22135"],"URL":"https:\/\/doi.org\/10.1038\/srep22135","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,2,24]]},"assertion":[{"value":"3 March 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"22135"}}